Intercept: 2Q Earnings Snapshot

August 2, 2018

NEW YORK (AP) _ Intercept Pharmaceuticals Inc. (ICPT) on Thursday reported a loss of $75.9 million in its second quarter.

The New York-based company said it had a loss of $2.58 per share.

The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $2.83 per share.

The drugmaker posted revenue of $43.6 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $39.9 million.

Intercept shares have climbed 57 percent since the beginning of the year. The stock has declined 17 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ICPT at https://www.zacks.com/ap/ICPT

Update hourly